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ABSTRACT 
 
Alteration in Oligodendroglial Lineage Progression Following Exposure to BPA in 
Vitro. (May 2012) 
 
Grace Philip 
Department of Biomedical Science 
Texas A&M University 
 
Research Advisor: Dr. C. Jane Welsh 
Department of Veterinary Integrative Biosciences 
 
Multiple Sclerosis is an autoimmune disease characterized by demyelination and 
remyelination resulting in motor, sensory, visual, and autonomic dysfunctions that 
accumulate over time. Demyelination is thought to be caused by autoreactive 
lymphocytes that cross the highly regulated blood-brain barrier made of cerebral 
endothelial cells. Oligodendrocytes in the central nervous system  synthesize myelin-
related proteins, but a malfunction in the cell differentiation may contribute to improper 
myelination of the neuron or the inability to remyelinate after an autoimmune attack. A 
key environmental risk factor for MS is thought to be the widely used plasticizer 
bisphenol A (BPA). This study investigated the role on BPA as an etiologic agent of MS 
progression by investigating the changes induced in the OPC maturation cycle through 
BPA exposure at different concentrations. Quantification through differential 
immunohistochemical staining was analyzed by statistical tests.   
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CHAPTER I 
INTRODUCTION 
 
Multiple Sclerosis (MS) is an autoimmune inflammatory disease of the brain and spinal 
cord. The early disease is characterized by demyelination and remyelination that is 
clinically manifested in neurological dysfunctions of the motor, sensory, visual, and 
autonomic systems. This demyelinating disease is pathognomonically characterized by 
the formation of sclerotic plaques which are areas of inflammation and demyelinated 
axons. Clinically, 80% of patients with the above listed manifestations of demyelination 
undergo a relapsing-remitting cycle of multiple sclerosis where the patients have an 
incomplete recovery after each episode only to experience persistent, disabling, and 
accumulating symptoms in the future. Eventually at around 40 years of age, or after 
several decades the disease progresses and evolves to cause complications due to 
infections of the skin, chest, and bladder, depression from cerebral inflammation or the 
restrictions and uncertainties in nearly half of the patient sample, or death in nearly two-
thirds of the cases (Compston and Coles, 2008).  
 
Axons are only able to propagate the electrochemical signal in neurons effectively 
through insulation provided by myelin. Myelin is a protein-lipid complex that wraps 
_______________ 
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around the axon and is secreted by oligodendrocytes, a macroglial cell present in the 
Central Nervous System (CNS). Oligodendrocytes exist first as pleuripotent neural stem 
cells, second as oligodendrocytes progenitor cells (OPC) in the dorsal spinal cord and 
telecephalon, then finally as pre-oligodendrocytes. Upon stimulation, OPC migrate to 
developing axons, exit the cell cycle, and differentiate into mature oligodendrocytes that 
produce myelin- related proteins. The oligodendrocytes continue to maintain the myelin 
membrane which consists of continual turnover of myelin and high myelin gene 
expression (Miron et al., 2010). Demyelination occurs as lymphocytes cross the blood-
brain barrier (BBB) and attack the myelin covering. The BBB is an organization of 
cerebral endothelial cells that separate the cerebral vascular compartment from the 
cerebral interstitium. A functioning BBB sequesters the CNS from influx of blood 
elements and humoral neurotransmitters; consequently, breakdown or dysregulation of 
this barrier allows migration of activated leukocytes (Minagar and Alexander, 2003). 
Therefore, in demyelination, the potassium ions leakage results in a failure to conduct 
action potentials and is clinically manifested in motor and sensory dysfunctions 
(Compston and Coles, 2008; Standring and Gray, 2008) 
 
There are several factors that can lead to or exacerbate the condition of Multiple 
Sclerosis in a population. Environmentally, there is a generalized increase in global 
distribution at latitudes at a greater distance from the equator. For example, the disease is 
common in the Northern European population. Multiple Sclerosis has also been 
associated with infections of measles, mumps, rubella, and Epstein- Barr virus at later 
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ages and also a higher risk of relapse after upper respiratory and gastrointestinal 
infections. Other environmental triggers can be due to low sunlight, vitamin D 
deficiency, smoking, and pollutants (Compston and Coles, 2008). Multiple Sclerosis is 
also more common in females than males with the trend of decreasing relapse rates 
during pregnancies and increases sensitivity to estrogen levels (Whitacre et al., 1999). 
 
In the last half century there has been an increased incidence of Multiple Sclerosis 
worldwide. Although this increase may be attributed to the improved methods of 
detection and reporting, researchers hypothesize the change may arise from 
environmental risk factors (Noonan et al., 2001). The most noteworthy environmental 
risk factor includes the abundant use of bisphenol A (BPA). BPA is a plasticizer used 
worldwide in the production of plastics and epoxy resins in most everyday products. Its 
use includes food and drink containers, dental enamels, and linings of food cans. BPA 
has been found in body fluids, fetal serum, and full-term amniotic fluid. It can enter the 
body by product contamination, leakage from these food containers into the food, or 
contact with products (Vandenberg et al., 2007; Whitacre et al., 1999).  Its presence in 
these body fluids indicates that BPA can pass the placental barrier, though it is found at 
higher levels in the maternal blood because of the hemochorial placentation of humans 
(Brown Jr., 2009). However, given the passing of BPA to the fetus, there is a high 
chance that the developing fetus will contain this compound at high levels during the 
formative weeks of neurological development. 
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Bisphenol A is classified into a group of drugs that are known as endocrine disrupting 
compounds (EDC). EDC are a class of environmental contaminants that cause an 
abnormal endocrine milieu in the human body. BPA, in particular, imitates estrogen and 
binds to estrogen receptors (Welshons et al., 2003). Once bound, BPA sets off a cascade 
of endocrine related diseases that are naturally supposed to have activation from the 
endogenous source of estrogen and not exogenous estrogenic imitators (Yamaguchi et 
al., 2006). For this reason, BPA is implicated for schizophrenia, prostate cancer, early 
puberty, neoplastic lesions, and reduced mammary gland and altered breast development 
(Diamanti-Kandarakis et al., 2009).  
 
 In addition to its presence, BPA was discovered to have neurological effects in astrocyte 
progenitor cells. Astrocytes are found in abundance exclusively in the central nervous 
system and have a variety of functions including forming the highly selective blood 
brain barrier, functioning as antigen presenting cells to T-cells, and recruiting 
macrophages in the central nervous system with chemokines (Minagar et al., 2002). At 
in vitro dosages, BPA causes serum-free mouse embryo cells, the astrocyte progenitor 
cell, to increase production of glial fibrillary acidic protein, thereby showing that BPA 
causes astrocytes to mature fast. This poses a problem in vivo because astrocytes 
normally appear in the brain during the late terms and early postnatal stages to help 
guide axons to the desired and appropriate synapse (Yamaguchi et al., 2006). 
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BPA is found to bind to thyroid hormone receptors and antagonize the production of T3 
thereby reducing the production of T3 gene expression in vitro (Zoeller 2005). This 
finding is significant because the oligodendrocytes differentiate and mature in the active 
form through binding of thyroid hormone to the thyroid hormone receptor. Therefore, 
the lack of thyroid hormone presence in the developing brain will inhibit the myelination 
of axons in the fetus (Seiwa et al., 2004). The negative effects of the thyroid hormone 
inhibition due to BPA can be traced to the myelin basic protein (MBP). MBP is found to 
be upregulated in the brain due to thyroid hormone release. MBP plays a key role as a 
protein in the overall structure of myelin, the phospholipid membrane that protects and 
insulates the axon and travelling electrochemical signal of the neuron (Farsetti et al., 
1991). However in a brain undergoing secondary hypothyroidism due to BPA, there is a 
marked decrease in MBP production (Zoeller et al., 2000). This finding has been 
substantiated in an in vitro study that found BPA to inhibit the expression of MBP at 
doses of 10
-5
 M (Seiwa et al., 2004). Due to all of the research supporting the 
physiological and endocrine disrupting effects of BPA, the current investigation focuses 
on the potential role of BPA in the etiology of MS by examining its effects on 
oligodendroglial cells.  
 
 
 
 
 
  6 
Objectives 
The purpose of this project was to investigate the effect of BPA on oligodendrocytes 
development in order to explore the relationship between Multiple Sclerosis and BPA. 
Previous studies have focused on specific aspects of the disease, but this approach  for 
assessing the developmental changes of oligodendrocytes and provides holistic 
information about the role on BPA on OPC maturation. Furthermore, this project 
provides more information about the myelination process of oligodendrocytes and 
susceptibility to Multiple Sclerosis by assessing the cytotoxic, maturation, and 
proliferative effects of BPA on oligodendrocytes progenitor cells. 
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CHAPTER II 
 
METHODS 
 
 
Primary mixed glial cultures were prepared from the forebrains of 1- to 2-day-old 
C57Bl/6 mice using a differential detachment method as detailed previously (Li et al. 
2008) and provided to Dr. Brinkmeyer and Ms Philip for analysis. Briefly, mixed glial 
cultures were grown in poly-D-lysine coated culture plates or in flasks for individual cell 
type isolation. Pre-oligodendrocytes isolated from mixed glial cultures were maintained 
in growth medium, i.e., the serum-free Basal Defined Medium (BDM) (Dulbecco’s 
modified Eagle’s medium, 0.1% bovine serum albumin, 50 lg/mL human apo-
transferrin, 50 lg/mL insulin, 30 nM sodium selenite, 10 nM D-biotin and 10 nM 
hydrocortisone) supplemented with platelet-derived growth factor (10 ng/mL) and basic 
fibroblast growth factor (10 ng/mL) for 5–9 days in order to promote progenitor 
proliferation (Chen et al., 2007; Kim et al., 2011). 
 
Oligodendroyte cells cultures were set up in triplicate and were treated for 48 hours  with 
BPA dissolved in a methanol, a medium vehicle, at concentrations of 10
-3
 M and 10
-4
 M 
due to preliminary data showing most obvious morphological differences at these 
concentrations (Chen et al., 2007). Controls were cells treated with vehicle alone. After 
washing. After washing with a phosphate-buffered saline and 4% paraformaldehyde, 
cells were immunostained with O4 antibody (1:500 dilution). Total number of cells was 
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revealed by staining all nuclei with Hoechst 33258. Five random consecutive fields were 
counted in each coverslip under 200 magnification with a total great than 1000 cells 
counted in the control conditions.  
 
According to Figure 1, oligodendrocyte stages are identified by their expression of 
antigens identified by specific antibodies. After washing with a saline solution and 
fixation with a 4% paraformaldehyde for 10 minutes, cells were stained with A2B5 and 
Ki67 antibodies to detect oligodendrocyte precursor and proliferating cells, respectively. 
O4 and PLP (proteolipid protein) antibodies identify late progenitor and mature 
oligodendrocytes, respectively. The slides were blocked with Tris-buffered saline (TBS)-
T (50 mM Tris–HCl, pH 7.4/150 mM NaCl/0.1% Triton X-100) or TBS (for O4 
immunostaining) containing 5% goat serum. The coverslips were then incubated with 
antibody O4 (1: 500) or antibody to PLP (1: 1000) overnight at 4°C. After washes, 
secondary antibody conjugated with either Alexa Fluor 488 or Alexa Fluor 594 (1: 1000 
dilution, Molecular Probes, Eugene, OR, USA) was incubated with the coverslips for 1 
hour at 25°C. Following more washes, nuclei were stained with Hoechst 33258 at a final 
concentration of 2 µg/mL for 1 min. The coverslips were then washed two to three times 
and mounted onto glass slides with FluoroMount and kept in the dark at 4°C. Cell 
images were captured with a fluorescence microscope (Olympus IX71) equipped with an 
Olympus DP70 digital camera (Leeds Instruments, Irving, TX, USA). 
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Figure 1: Defining glial cells during CNS development. The four stages of oligodendroglial 
lineage is differentiated by either A2B5, PDGFRα, NG2, O4, O1, CNPase, and PLP. 
  
 
Cell counting software, Image J, was used to quantify samples by counting co-localized 
nuclei and cell bodies 
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CHAPTER III 
RESULTS 
 
Oligodendrocyte precursor cell cultures were assessed for maturation, proliferation, and 
apoptosis due to BPA exposure. To accomplish this, OPC were grown BDM media and 
divided up into three different treatment groups according to the molar concentration of 
BPA given: 10
-3
 M, 10
-4
 M, or a control group which was untreated. After 4% 
paraformaldehyde fixation, each experimental subgroup was subjected to 
immunohistochemistry to identify cells in the different stages of oligodendrocyte 
lineage, assess cell number, and note cell death through apoptosis. 
 
To assess the cytotoxic effect of BPA, OPC were stained with DAPI, a DNA fluorescent 
stain that identifies cell nucleus with a blue color (Kapuscinski, 1995), and TUNEL 
staining, a red fluorescent probe that binds to apoptotic nuclei (Grasl-Kraupp et al., 
2005. After imaging, images were analyzed for the percentage of TUNEL-positive 
nuclei present. Cell positive for TUNEL had a colocalized blue-red coloration whereas 
cells negative for apoptosis just appeared blue. Figure 2 is a representative image of 
OPC treated at a concentration of 10
-3
 M with BPA.  For statistical analysis, all images 
were counted for the total number of TUNEL-positive cells as a percentage of the total 
number of cells visible in the image. Table 1 shows the averages across the three 
different treatment groups.  However for a better representation of the group differences, 
Figure 3 offers a comparison.  
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DAPI 
TUNEL 
DAPI/TUNEL 
Figure 2: TUNEL immunohistochemistry for cell apoptosis. OPC treated with 10
-3
 M 
BPA for 48 hours. A) DAPI stain B) TUNEL stain C) DAPI and TUNEL. 
Representative image showing 33.3% of OPC positive for TUNEL post-treatment. 
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Figure 3: Comparison of Percentages of TUNEL positive cells. Groups are 
divided by the molar concentration of BPA administration 
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As the trend shows, more cells are positive for TUNEL at 10
-3
 M than at 10
-4
 M and 
untreated cells. Samples treated with 10
-3
 M BPA had on average 22.12 ± 9.88 percent 
TUNEL expression. Samples treated with 10
-4
 M BPA had on average 13.26 ± 2.87 
percent TUNEL expression, and samples left untreated with BPA have 14.37 ± 5.46 
percent TUNEL expression. As seen in Figure 2, artifact and nuclei were objectively 
stained with TUNEL. These could be remnants of OPC that had lysed and left their 
fragments in the culture or they can be inconsequential contaminants from the medium 
or staining agent. Aside from the artifact, TUNEL samples were straightforward in the 
co-localization and counting.  
 
To assess maturation, OPC were stained for the presence of 04, an antigen present on the 
pre-oligodendroglial stage of oligodendrocytes, and PLP, a protein expressed by 
myelinating oligodendrocytes, and again with DAPI. Although the presence of O4 
 Average Standard Deviation 
10
-3
 M BPA 22.12 9.88 
10
-4
 M BPA 13.26 2.87 
Control 14.37 5.46 
Table 1: Percentages of TUNEL positive cells in treatment samples. Sample groups 
are divided by the concentration of BPA administered. Column 1 is the average 
percentage of TUNEL positive in each group. Column 2 is the standard deviation of 
the sample percentages.  
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proceeds that of PLP in the lineage, O4 expression continues even as the 
oligodendrocyte is fully mature and functional. Immunostaining of O4 appears as a red 
cytoplasmic stain. PLP staining is identified by a green cytoplasmic stain that when 
present with O4-positive cells co-localizes to produce a yellow color. DAPI verifies the 
presence of a nucleated cell. Figure 4 is a representative image of the staining of OPC 
treated for 48 hours with 10
-3
 M BPA. Each of the images stained were assessed to find 
the percentage of cells that fell into one of three groups: O4-positive and PLP-positive 
while staining with DAPI, O4-positive and DAPI-positive, or DAPI-positive. The 
percentages were averaged across each BPA treatment group. The results are tabulated 
in Table 2. For a better view of the expression of PLP or O4 across the BPA treatment 
groups, Figure 5 compares the percentage of cells that expressed a certain phenotype 
depending on the concentration of BPA administered for 48 hours.  
 
 
 
 
 
 
 
 
  PLP+O4+DAPI O4+DAPI DAPI 
10
-3
 M BPA Average 44.46 52.24 3.31 
 Standard Deviation 18.13 17.23 3.99 
10
-4
 M BPA Average 41.43 51.45 7.12 
 Standard Deviation 9.36 6.55 4.90 
Control Average 50.04 41.97 7.99 
 Standard Deviation 15.00 12.07 5.23 
Table 2: Average Percentages for O4-positive and PLP-positive cells. 
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Figure 4: O4 and PLP immunohistochemistry for cell maturation. OPC treated for 
48 hours with 10
-3
 M BPA. A) O4 stain B) DAPI stain C) PLP stain D) merged 
image with DAPI, O4, and PLP. Representative image shows that 33.3% of OPC 
express all three antigens, 63.3% express only O4 and DAPI, and 3.33% express 
only DAPI.  
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Expression of PLP, O4, and DAPI is the highest in the control group, second highest in  
the cells treated at 10
-3
 M, and least of all by the OPC treated at 10
-4
 M. O4 and DAPI 
expression is the highest at a concentration of 10
-3
 M, then 10
-4
 M, and least expressed 
on the control group. There are more cells that only express DAPI in the control group 
than in the 10
-3
 M treatment group and 10
-4
 M treatment group.  
-5.00 
0.00 
5.00 
10.00 
15.00 
20.00 
25.00 
30.00 
35.00 
40.00 
45.00 
50.00 
55.00 
60.00 
65.00 
70.00 
PLP+O4+DAPI O4+DAPI DAPI 
P
e
rc
e
n
ta
ge
 (
%
) 
10-3 M BPA 
10-4 M BPA 
Control 
Figure 5: Comparison of Average Percentages of PLP and O4 expression. Groups are 
organized based on which concentration of BPA was administered as well as the 
expression of a combination of antigens. 
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To assess proliferative effects of BPA on OPC, cells were immunostained for the 
presence of A2B5, Ki67, and DAPI. A2B5 is an antigen present on oligodendrocyte 
precursor cells and Ki67 is present on all cells that are participating in the proliferative 
cell cycle. The only cells in the oligodendrocytes lineage that actively divide or have 
recently divided are the oligodendrocytes precursor cells. A2B5 is a red cytoplasmic 
immunostain. Ki67 is a green nuclear stain that varies in its intensity of expression 
depending on the stage in which the cell is currently present (Brown and Gatter, 1990). 
Figure 6 offers a representative sample of OPC treated with 10
-3 
M BPA and assessed for 
immaturity and proliferation. The cells are group based on whether they fall into one of 
two groups: Ki67-positive and A2B5-positive while expressing DAPI or A2B5-positive 
and DAPI-positive. Table 3 summarizes the average findings for each of the treatment 
groups. As evidenced by the data, nearly 100% of each of the treatment groups 
expressed Ki67 and A2B5. There were not any samples that had cells that solely 
expressed DAPI without A2B5.  
 
  DAPI+A2B5+ Ki67 A2B5 + DAPI 
10
-3
 M BPA Average 99.8 0.2 
 Standard 
Deviation 
0.5 0.5 
10
-4
 M BPA Average 99.8 0.2 
 Standard 
Deviation 
0.4 0.4 
Control Average 99.5 0.5 
 Standard 
Deviation 
0.9 0.9 
Table 3: Average Percentages for Ki67-positive, A2B5-positive for cell proliferation 
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Figure 6: Immunohistochemical analysis for cell proliferation and immaturity with 
A2B5, Ki67, and DAPI. OPC were treated for 48 hours with 10-3 M BPA.   
A2B5 
DAPI 
Ki67 
DAPI/ A2B5/ Ki67 
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The greatest problem posed to the acquisition of the results came from the images 
themselves. Many of the images captured by immunofluorescence appeared blurry. Also 
the immunostains for specific antigens often stained the background, giving the 
appearance that everything in the sample included the stain. To reconcile this issue, all 
cells that expressed even a faint level of immunofluorescence that indicated the presence 
of an antigen were counted as positive for the antigen. This was done because 
physiologically the faint expression of an antigen is indicative of the cell stage and 
should not be ignored.  Furthermore many of the images had greater than 150 cells 
which is not an ideal range of values to attempt to get statistically significant differences 
in counts because the difference of ten cells holds greater value at lower counts than at 
higher counts where the difference is dilute.  
 
 
 
 
 
 
 
  
  20 
CHAPTER IV 
CONCLUSIONS 
 
One of the aims of this project was to assess whether or not BPA had cytotoxic effects 
on OPC. If BPA caused cell death in oligodendrocytes, then that may provide an 
understanding of the increased incidence of multiple sclerosis and other neurological 
disorders associated with malfunctioning of myelinated neuronal pathways. The data 
showed that at high levels of BPA around 10
-3
 M, cells showed a 22% expression of 
TUNEL, therefore showing that around 22% of cells exposed to BPA underwent 
apoptosis. This value is higher than those found at 10
-4
 M or untreated samples which 
each had about 13% and 14% apoptosis, respectively. Therefore it can be assumed that 
high levels of BPA may induce apoptosis in oligodendrocyte precursor cells.  
 
 However, the nature of the TUNEL stain itself poses a challenge to data gathered. 
TUNEL binds to spliced ends of DNA that become exposed after DNA terminal 
deoxyribonucleotidyl transferase has cleaved DNA. However TUNEL cannot 
differentiate between apoptosis, necropoptosis, or autolysis (Grasl-Kraupp et al., 2005). 
Therefore we are unable to definitively assess the mode of the cell death observed. 
However the fact that we observed  dose response of more cell death in the higher 
concentrations of BPA suggests that BPA is having a toxic effect on oligodendrocytes.   
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BPA has been previously proven to cause the early maturation of astrocyte progenitor 
cells in vitro (Yamaguchi et al., 2006). If the same trend of BPA applies to 
oligodendrocyte precursor cells, then the early maturation of this endocrine disrupting 
compound may cause premature myelination of incomplete pathways in neonates/ 
infants. To study this effect, OPC cultures treated at different concentrations were 
immunostained with antibodies to proteolipid protein (PLP) and O4. O4 is present on the 
proligodendrocytes that have exited the cell cycle, ceased cell proliferation and 
migration, grown several processes, and lacks expression of A2B5 on the cytoplasm. 
PLP is only present on the terminal stage of the oligodendrocytes lineage on cells that 
are actively myelinating axons. The presence of one or both of these antigens through 
the immunohistochemical assay is indicative of early maturation. 
 
According to the data collected the percentage of immature oligodendrocytes that lack 
both PLP and O4 expression in all three treatment groups, on average, falls under 10% 
of the total cell population. Cultures treated with 10
-3
 M BPA have the least amount of 
immature oligodendrocytes at an average percent of 3.31%. Cells that are left untreated 
and that have a lower BPA administration average around 7.99% and 7.12% 
respectively. This result was predicted by previous publications. Interestingly, the 
control samples had the highest average percentage of mature oligodendrocytes that 
expressed PLP, O4, and DAPI around 50%. It was expected that cells that were treated 
with BPA should express the higher percentage of fully mature oligodendrocytes. This 
anomaly in the results can arise from a number of sources, but probably came from 
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human error in data interpretation. Cells treated with 10
-3
 M and 10
-4
 M of BPA had 
similar average percentage of O4-positive and DAPI-positive cells at 52.24% and 
51.45%, respectively. However, cells treated with 10
-3
 M BPA had the greatest range 
and the highest average percentages of the experimental samples. This trend follows 
what was predicted, showing that higher concentrations of BPA cause OPC to mature 
into proligodendrocytes.  
 
BPA imitates estrogen on the thyroid gland and decreases the output of Thyroid 
Hormone. Thyroid Hormone plays a key role in the maturation of oligodendrocytes so 
the inhibition of thyroid hormone will inhibit the maturation of oligodendrocytes by 
proxy. The final aim to assess the proliferation of OPC after exposure to BPA highlights 
the fact that immature progenitor oligodendrocytes that express A2B5 will be the cells 
undergoing the most proliferation and expressing Ki67. Ki67 is present on all stages of 
the proliferative cell cycle at varying degrees depending on the stage. However, Ki67 is 
not present on cells that have exited the cell cycle, are arrested at G0-phase, and have 
stopped proliferation (Brown and Gatter, 1990). 
 
According to the data acquired through the final aim, essentially 99% of the cells in 
samples treated with 10
-3
 M BPA, 10
-4
 M BPA, and untreated cells displayed A2B5 and 
Ki67.  Therefore, regardless of treatment of BPA, a majority of OPC remained 
immature. It would have been expected to see that only those cultures treated with BPA 
stayed in their proliferative, immature cycle, but even the untreated cells expressed 
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A2B5 and Ki67. This can be attributed to the fact that oligodendrocytes in vitro often 
stay immature for up to 3 days, at which point they stop expressing A2B5 and begin 
expression of O4. As previously mentioned, the difficultly in deciding whether to count 
the faded stain as artifact or significant probably contributed to the high immature 
population in the untreated control samples.  
 
The data gained from this project has certainly shown the influence of BPA exposure on 
oligodendroglial lineage progression. BPA has caused OPC to undergo apoptosis or 
related cell death. It has also caused OPC to mature at a faster rate and decrease the 
concentration of immature cells in vitro. Furthermore it has caused the same OPC to 
remain in a period of cell immaturity and proliferation. In conclusion, low doses of BPA 
have a detrimental effect on oligodendrocytes viability and development, which may 
contribute to the pathogenesis of multiple sclerosis and explain, in part, the increased 
incidence of disease. 
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Future directions 
The data gathered has opened up new information about the physiological changes due 
to BPA. But there is a need to delve into the root of the matter and explore the changes 
BPA poses on the genetic level. In a future experiment, it will be useful to extract RNA 
from in vitro cultures of OPC treated with BPA as well as in vivo cultures of mouse 
OPC fed BPA. The extracted RNA can then be analyzed for epigenetic changes such as 
methylation, acetylation, and other chromatin modifications as induced by BPA 
exposure. This information will provide thorough information about any additional 
effects of BPA on OPCs. 
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